IgG Glyco-Engineering to Improve IVIg Potency

Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsonized blood cells by saturation of the Fc-gamma rece...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Bruggeman, Christine W., Dekkers, Gillian, Visser, Remco, Goes, Naneth W. M., van den Berg, Timo K., Rispens, Theo, Vidarsson, Gestur, Kuijpers, Taco W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2018
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206079/
https://ncbi.nlm.nih.gov/pubmed/30405631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02442
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk